Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016:2016:6267406.
doi: 10.1155/2016/6267406. Epub 2016 Sep 7.

Medication-Related Osteonecrosis of Jaws: A Low-Level Laser Therapy and Antimicrobial Photodynamic Therapy Case Approach

Affiliations

Medication-Related Osteonecrosis of Jaws: A Low-Level Laser Therapy and Antimicrobial Photodynamic Therapy Case Approach

Mariana Comparotto Minamisako et al. Case Rep Dent. 2016.

Abstract

Medication-related osteonecrosis of the jaws (MRONJ) can be considered an inability of the alveolar bone to respond to an injury, which frequently leads to severe local and systemic complications. Once the problem is installed, dentist must use all therapeutic approaches recommended. This manuscript reports a successful management of MRONJ handled with antibiotics, conservative debridement, low-level laser therapy (LLLT), and photodynamic therapy (PDT) up to 12 months. As healing of MRONJ may be very slow, combined therapeutic approaches are required. Besides the recommended conventional treatment protocol, LLLT and PDT are important tools to contribute to healing and improvement of patient's quality of life.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Clinical aspect of bone exposure measuring approximately 1.5 cm at vestibular sulcus of right maxilla (a). CT showing bone lysis and necrotic bone sequestrum at maxilla with oral antral communication risk (b). Clinical aspect of vestibular sulcus mucosa totally recovered after 37 sessions of LLLT and PDT (c).

References

    1. Cheng A., Daly C. G., Logan R. M., Stein B., Goss A. N. Alveolar bone and the bisphosphonates. Australian Dental Journal. 2009;54(1):S51–S61. doi: 10.1111/j.1834-7819.2009.01143.x. - DOI - PubMed
    1. Hellstein J. Osteochemonecrosis: an overview. Head and Neck Pathology. 2014;8(4):482–490. doi: 10.1007/s12105-014-0583-z. - DOI - PMC - PubMed
    1. Bell B. M., Bell R. E. Oral bisphosphonates and dental implants: a retrospective study. Journal of Oral and Maxillofacial Surgery. 2008;66(5):1022–1024. doi: 10.1016/j.joms.2007.12.040. - DOI - PubMed
    1. Shannon J., Shannon J., Modelevsky S., Grippo A. A. Bisphosphonates and osteonecrosis of the jaw. Journal of the American Geriatrics Society. 2011;59(12):2350–2355. doi: 10.1111/j.1532-5415.2011.03713.x. - DOI - PubMed
    1. Mehanna P., Goddard R. Bisphosphonate associated osteonecrosis: an unusual case. Australian Dental Journal. 2010;55(3):311–313. doi: 10.1111/j.1834-7819.2010.01240.x. - DOI - PubMed

LinkOut - more resources